Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Zolpidem tartrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zolpidem tartrate and what is the scope of zolpidem tartrate patent protection?

Zolpidem tartrate
is the generic ingredient in seven branded drugs marketed by Torrent Pharms, Dr Reddys Labs Inc, Sandoz, Sanofi Aventis Us, Par Form, Teva, Biovail Labs Intl, Aurobindo Pharma, Allied Pharma Inc, Mylan Pharms Inc, Vintage, Sandoz Inc, Wockhardt, Purdue Pharma, Hikma, Synthon Pharms, Anchen Pharms, Actavis Labs Fl Inc, Sun Pharm Inds Ltd, Sun Pharm Inds Inc, Vivimed Labs, Apotex Inc, Lupin Ltd, Sun Pharma Global, Watson Labs, Mylan, Actavis Elizabeth, Invagen Pharms, Dr Reddys Labs Ltd, Cipla Ltd, Sun Pharm Inds, Yung Shin Pharm, Amherst Pharms Llc, Mylan Speciality Lp, and Novel Labs Inc, and is included in thirty-nine NDAs. There are twelve patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Zolpidem tartrate has two hundred and twenty-two patent family members in thirty-six countries.

There are thirty-one drug master file entries for zolpidem tartrate. Sixty-six suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: zolpidem tartrate

Drug Master File Entries: see list31
Suppliers / Packagers: see list66
Bulk Api Vendors: see list30
Clinical Trials: see list99
Patent Applications: see list908
Therapeutic Class:Sedatives/Hypnotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zolpidem tartrate at DailyMed

Pharmacology for Ingredient: zolpidem tartrate

Tentative approvals for ZOLPIDEM TARTRATE

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe5MGTABLET;ORAL
► Subscribe► Subscribe10MGTABLET;ORAL
► Subscribe► Subscribe10MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
zolpidem tartrate
TABLET, EXTENDED RELEASE;ORAL200266-001Sep 10, 2013ABRXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
zolpidem tartrate
TABLET;SUBLINGUAL202657-002Aug 8, 2016ABRXNoNo► Subscribe► Subscribe
Vivimed Labs
zolpidem tartrate
TABLET;ORAL076062-001Apr 23, 2007DISCNNoNo► Subscribe► Subscribe
Watson Labs
zolpidem tartrate
TABLET;ORAL077773-002Apr 23, 2007DISCNNoNo► Subscribe► Subscribe
zolpidem tartrate
TABLET;ORAL076410-001Apr 23, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus